1. Lilly Answers that Matter

2. Preserving the Value of Industry Interactions with Health Care Professionals Jack Harris, M.D. Vice President, U.S. Medical Division

3. Lilly Core Values Integrity Excellence Respect for People

4. Lilly Ethics in Action The Red Book Chief Compliance Officer Comprehensive Compliance Program Training, Testing, Auditing Ethics and Compliance Hotline Principles of Medical Research Conduct of research Payments to health care providers Communications of research results Bioethics Committee

5. Lilly Supports Transparency Clincal Trial Registry Grants Registry Payments to Physicians Registry Physician Payment Sunshine Act

6. Biopharmaceutical Industry Efforts PhRMA Principles on Conduct of Clinical Trials PhRMA Communication of Clinical Trial Results PhRMA Code on Interactions with Health Care Professionals AdvaMed Code of Ethics

7. IOM Report Interactions between biopharmaceutical company representatives, physicians, and researchers are legal, ethical, and appropriate Policies should be implemented to identify and manage potential conflicts of interest without damaging constructive collaborations among those parties